{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:39:01Z","timestamp":1790883541194,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.4158\/ep.7.4.279","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:37:39Z","timestamp":1365205059000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome"],"prefix":"10.1016","volume":"7","author":[{"given":"Zachary T.","family":"Bloomgarden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Futterweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Poretsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP.7.4.279_bb0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00006254-199906000-00024","article-title":"Polycystic ovary syndrome: clinical perspectives and management","volume":"54","author":"Futterweit","year":"1999","journal-title":"Obstet Gynecol Surv"},{"key":"10.4158\/EP.7.4.279_bb0015","series-title":"Androgenic Disorders","first-page":"77","article-title":"Pathophysiology of polycystic ovary syndrome. In","author":"Futterweit","year":"1995"},{"key":"10.4158\/EP.7.4.279_bb0020","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.7.4.279_bb0025","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperan- drogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.7.4.279_bb0030","first-page":"251","article-title":"The role of the adrenal in polycystic ovary syndrome","volume":"2","author":"Lobo","year":"1984","journal-title":"Semin ReprodEndocrinol"},{"key":"10.4158\/EP.7.4.279_bb0035","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/jcem-56-5-897","article-title":"Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist","volume":"56","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0040","series-title":"Androgen Excess Disorders in Women","first-page":"625","article-title":"Clinical evaluation of androgen excess. In","author":"Futterweit","year":"1997"},{"key":"10.4158\/EP.7.4.279_bb0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965 a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"10.4158\/EP.7.4.279_bb0050","series-title":"Polycystic Ovary Syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In","author":"Zawadsky","year":"1992"},{"key":"10.4158\/EP.7.4.279_bb0055","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2014 a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"10.4158\/EP.7.4.279_bb0060","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI108400","article-title":"Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome","volume":"57","author":"Rebar","year":"1976","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.7.4.279_bb0065","first-page":"51","article-title":"Le virilisme pilaire et son association a l\u2019 insuffisance glycolytique (diabete des femmes a barbe)","volume":"86","author":"Archard","year":"1921","journal-title":"Bull Acad Nat Med"},{"key":"10.4158\/EP.7.4.279_bb0070","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jama.1925.02670060022007","article-title":"The growth, development and prognosis of diabetic children","volume":"85","author":"Joslin","year":"1925","journal-title":"JAMA"},{"key":"10.4158\/EP.7.4.279_bb0075","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.7.4.279_bb0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.170678","article-title":"Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance","volume":"190","author":"Flier","year":"1975","journal-title":"Science"},{"key":"10.4158\/EP.7.4.279_bb0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2337\/diab.43.2.247","article-title":"Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance","volume":"43","author":"Moller","year":"1994","journal-title":"Diabetes"},{"key":"10.4158\/EP.7.4.279_bb0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/0003-4819-97-6-851","article-title":"Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor","volume":"97","author":"Taylor","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.7.4.279_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0105","first-page":"613","article-title":"Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome","volume":"84","author":"Poretsky","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP.7.4.279_bb0110","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0026-0495(92)90175-A","article-title":"Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats","volume":"41","author":"Poretsky","year":"1992","journal-title":"Metabolism"},{"key":"10.4158\/EP.7.4.279_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.7.4.279_bb0120","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(16)53699-1","article-title":"Clinical signs of androgen excess as risk factors for coronary artery disease","volume":"54","author":"Wild","year":"1990","journal-title":"Fertil Steril"},{"issue":"8 Pt 1","key":"10.4158\/EP.7.4.279_bb0130","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0895-7061(99)00048-5","article-title":"The relationship of serum androgens and ovulatory status to blood pressure in reproductive-age women","volume":"12","author":"Ayala","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.4158\/EP.7.4.279_bb0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.7.4.279_bb0140","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jcem-59-4-809","article-title":"Specific insulin binding sites in the human ovary","volume":"59","author":"Poretsky","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0145","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/jcem-61-4-728","article-title":"Distribution and characterization of insulin and insulinlike growth factor I receptors in normal human ovary","volume":"61","author":"Poretsky","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0015-0282(16)47243-2","article-title":"Effects of insulin on steroidogenesis in cultured porcine ovarian theca","volume":"40","author":"Barbieri","year":"1983","journal-title":"Fertil Steril"},{"key":"10.4158\/EP.7.4.279_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 1","key":"10.4158\/EP.7.4.279_bb0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/humrep\/12.suppl_1.82","article-title":"Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome","volume":"12","author":"Pasquali","year":"1997","journal-title":"Hum Reprod"},{"key":"10.4158\/EP.7.4.279_bb0165","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-68-6-1027","article-title":"Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome","volume":"68","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0170","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0015-0282(16)57842-X","article-title":"Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin- stimulated secretion in hyperinsulinemic women with polycystic ovary disease","volume":"64","author":"Fulghesu","year":"1995","journal-title":"Fertil Steril"},{"key":"10.4158\/EP.7.4.279_bb0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/edrv-8-2-132","article-title":"The gonadotropic function of insulin","volume":"8","author":"Poretsky","year":"1987","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.7.4.279_bb0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.7.4.279_bb0185","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"key":"10.4158\/EP.7.4.279_bb0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0195","first-page":"755","article-title":"Relationship between insulin sensitivity and circulating sex hormone-binding globulin levels in hyperandrogenic obese women","volume":"18","author":"Fendri","year":"1994","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.4158\/EP.7.4.279_bb0200","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/endo-122-2-581","article-title":"The effects of experimental hyperinsulinemia on steroid secretion, ovarian [125I]insulin binding, and ovarian [125I]insulin-like growth-factor I binding in the rat","volume":"122","author":"Poretsky","year":"1988","journal-title":"Endocrinology"},{"key":"10.4158\/EP.7.4.279_bb0205","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0002-9378(95)90024-1","article-title":"The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome","volume":"172","author":"Buyalos","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.4158\/EP.7.4.279_bb0210","first-page":"493","article-title":"Insulin receptor mediates inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-1, on IGF binding protein 1 (IGFBP-1) production in human granulosa cells","volume":"81","author":"Poretsky","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0215","first-page":"2057","article-title":"Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women","volume":"80","author":"Crave","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","article-title":"On the paradox of insulin-induced hyperan- drogenism in insulin-resistant states","volume":"12","author":"Poretsky","year":"1991","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.7.4.279_bb0225","first-page":"3110","article-title":"Selective insulin resistance in the polycystic ovary syndrome","volume":"84","author":"Book","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0230","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0235","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2337\/diacare.13.3.244","article-title":"Second messengers of insulin action","volume":"13","author":"Saltiel","year":"1990","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.7.4.279_bb0240","article-title":"Phosphatidylinositol-3 (PI-3) kinase independent insulin action pathway(s) in the ovary","author":"Poretsky","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0245","series-title":"Insulin Resistance","first-page":"9","article-title":"Mechanisms of insulin action. In","author":"White","year":"1993"},{"key":"10.4158\/EP.7.4.279_bb0250","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0255","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0260","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/humrep\/15.1.21","article-title":"Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome [erratum in Hum Reprod 2000;15:736]","volume":"15","author":"la Marca","year":"2000","journal-title":"Hum Reprod"},{"key":"10.4158\/EP.7.4.279_bb0270","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0015-0282(99)00407-0","article-title":"Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome [erratum inFertil Steril 2000;73:874]","volume":"72","author":"la Marca","year":"1999","journal-title":"Fertil Steril"},{"key":"10.4158\/EP.7.4.279_bb0275","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","article-title":"Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome","volume":"72","author":"De Leo","year":"1999","journal-title":"Fertil Steril"},{"key":"10.4158\/EP.7.4.279_bb0280","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0026-0495(99)90113-0","article-title":"Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"10.4158\/EP.7.4.279_bb0285","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0029-7844(97)00296-2","article-title":"Menstrual cyclicity after metformin therapy in polycystic ovary syndrome","volume":"90","author":"Velazquez","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP.7.4.279_bb0290","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.7.4.279_bb0295","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene- induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.7.4.279_bb0300","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2265.1999.00786.x","article-title":"The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"51","author":"Unluhizarci","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.7.4.279_bb0305","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0015-0282(98)00011-9","article-title":"Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome","volume":"69","author":"Morin-Papunen","year":"1998","journal-title":"Fertil Steril"},{"key":"10.4158\/EP.7.4.279_bb0310","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0315","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0320","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0325","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/humrep\/14.11.2700","article-title":"High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome","volume":"14","author":"Mitwally","year":"1999","journal-title":"Hum Reprod"},{"key":"10.4158\/EP.7.4.279_bb0330","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0015-0282(98)00454-3","article-title":"Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome","volume":"71","author":"Hasegawa","year":"1999","journal-title":"Fertil Steril"},{"key":"10.4158\/EP.7.4.279_bb0335","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2337\/diacare.17.12.1465","article-title":"Urinary chiro- inositol excretion as an index marker of insulin sensitivity in Japanese type II diabetes","volume":"17","author":"Suzuki","year":"1994","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.7.4.279_bb0340","series-title":"Molecular Biology of Diabetes: Part 2","first-page":"343","article-title":"Chiro-inositol deficiency and insulin resistance. In","author":"Craig","year":"1994"},{"key":"10.4158\/EP.7.4.279_bb0345","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome","volume":"340","author":"Nestler","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.7.4.279_bb0350","first-page":"1636","article-title":"Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome","volume":"77","author":"Ovesen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.1992.tb00958.x","article-title":"Lack of linear relationship between hyperinsulinaemia and hyperandro- genism","volume":"36","author":"Toscano","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.7.4.279_bb0360","first-page":"15","article-title":"Normalization of testosterone levels using a low estrogen- containing oral contraceptive in women with polycystic ovary syndrome","volume":"60","author":"Raj","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP.7.4.279_bb0365","first-page":"3821","article-title":"Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women","volume":"81","author":"White","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0370","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jcem.83.1.4500","article-title":"Hormonal effects of flutamide in young women with polycystic ovary syndrome","volume":"83","author":"De Leo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.7.4.279_bb0375","first-page":"89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20420269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20420269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/1TLVXT1F32VTANHF.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:41:28Z","timestamp":1761514888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20420269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S1530891X20420269"],"URL":"https:\/\/doi.org\/10.4158\/ep.7.4.279","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.7.4.279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}